Archives

by in
Entry Author Date Location
Aura Bio Gets $21M, Pivots to Rare Eye Cancers With Virus Nanotech 03/05/15 Boston
Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” 03/04/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Just Eight Days Left—Get Your Seat for “New York’s Life Science Disruptors” 03/04/15 New York
Top 3 Personal Health Tips From the Founders of Elysium 03/04/15 Boston
Blueprint Cuts $265M Alexion Deal With IPO in Sight 03/03/15 Boston
Focused on Glaucoma, Aerie Looks Toward Unblinding Critical Data 03/03/15 New York
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Paul Maritz Brings Cloud Expertise to Nanobiosym With Investment 02/26/15 Boston
New Harvard i-lab Head Talks Global Expansion, Startup Initiatives 02/26/15 Boston
Innovation Hub: Meet the Science Evangelist 02/20/15 National
WHO Approves 15-Minute Ebola Test Developed by Corgenix 02/20/15 Boulder/Denver
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
As New Sanofi CEO Starts, Viehbacher’s Biotech Fingerprints Abound 02/19/15 Boston
Fears Percolate as Billion-Dollar Private Company Valuations Climb 02/19/15 National
Social Network for Pharma’s Supply Chain TraceLink Grabs $20M Series B 02/18/15 Boston
Glaucoma Race Heats Up, But Inotek Cuts Back Its IPO to $40M 02/18/15 Boston
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets? 02/17/15 National
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
NIH Opens Discussion: How to Build a U.S. Health Research Database? 02/11/15 National
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
Breakout Labs Funds Lab Screening Startups and Stress Tracker System 02/10/15 San Francisco
Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans 02/09/15 Boston
“21st Century Cures” By Year’s End? Its Backers Want More Ideas 02/09/15 National
Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars 02/09/15 National
Page 1 of 92 next page »